FDA Investigator: Rochelle L. Cross

- Rochelle L. Cross first started conducting FDA inspections in 2002, with the last inspection in 2023. Over that time, Rochelle L. Cross has conducted 34 inspections at 32 companies across 34 sites.

Get Rochelle Cross's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Giacomina Massaro-Giordano M.D., Philadelphia | 2018

Out-of-stock
Rochelle L. Cross
Human Drug Form 483

FDA 483 Susan C. Taylor, MD, Philadelphia | 2017

Out-of-stock
Rochelle L. Cross
Medical Devices & Rad Health Form 483

FDA 483 Apotex Inc., Etobicoke | 2008

Out-of-stock
Rochelle L. Cross
Human Drug Form 483

FDA 483 GlaxoSmithKline Inc., Mississauga | 2008

Out-of-stock
Rochelle L. Cross
Human Drug Form 483

FDA 483 GlaxoSmithKline Inc., Mississauga | 2008

Out-of-stock
Rochelle L. Cross
Human Drug Form 483

FDA 483 Shanghai Sunve Baoling Pharmaceutical Factory, Shanghai | 2008

Out-of-stock
Rochelle L. Cross
Animal Drugs & Feed Form 483

FDA 483 Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd., Shanghai | 2008

Out-of-stock
Rochelle L. Cross
Animal Drugs & Feed Form 483

FDA 483 RA Chem Pharma Limited, Krishna District, AP | 2007

Out-of-stock
Rochelle L. Cross
Human Drug Form 483

FDA 483 Evonik Technochemie GmbH, Dossenheim | 2006

Out-of-stock
Rochelle L. Cross
Human Drug Form 483